O
OrbiMed’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.5M | Hold |
1,812,886
| – | – | 1.29% | 23 |
|
|
2025
Q1 | $53.5M | Buy |
1,812,886
+700,000
| +63% | +$20.7M | 1.28% | 25 |
|
|
2024
Q4 | $32.4M | Buy |
1,112,886
+68,081
| +7% | +$1.98M | 0.67% | 43 |
|
|
2024
Q3 | $48M | Buy |
1,044,805
+338,330
| +48% | +$15.5M | 0.87% | 33 |
|
|
2024
Q2 | $28.9M | Sell |
706,475
-287,625
| -29% | -$11.7M | 0.57% | 48 |
|
|
2024
Q1 | $25.4M | Buy |
+994,100
| New | +$25.4M | 0.46% | 58 |
|
|
2020
Q4 | – | Sell |
-63,860
| Closed | -$1.8M | – | 156 |
|
|
2020
Q3 | $1.8M | Sell |
63,860
-136,140
| -68% | -$3.83M | 0.02% | 134 |
|
|
2020
Q2 | $5.65M | Buy |
+200,000
| New | +$5.65M | 0.08% | 115 |
|